Artificial liver support systems bridge severe immune-mediated hepatotoxicity to clinical recovery

Background The incidence of hepatic immune-related adverse events has increased with the wide use of immune checkpoint inhibitors, some immune-mediated hepatotoxicity cases are severe and lack of clinical recommendations.